About 1,108,495 results (5,519 milliseconds)

US20080132474A1 - Breast cancer screening and treatment ...

https://patents.google.com/patent/US20080132474A1/en
Worldwide, breast cancer is now the leading cause of cancer mortality in women ... Breast tumors often, but do not always, have hormone receptors, more ...

US5543150A - Method of progesterone delivery and affect thereof ...

https://patents.google.com/patent/US5543150A/en
On the other hand, natural progesterone does not cause water retention ... Proliferation of the terminal duct lobular unit, from which most breast cancers ...

US8265359B2 - Computer-aided cytogenetic method of cancer ...

https://patents.google.com/patent/US8265359B2/en
Aug 27, 2009 ... ... hormone replacement therapy (HRT) and breast cancer. A meta-analysis ... Based on fair evidence, teaching breast self-examination does not reduce ...

WO2016049694A1 - Methods for assessing risk of developing ...

https://patents.google.com/patent/WO2016049694A1/en
In an embodiment, the female has not had breast cancer, lobular carcinoma or ductal carcinoma. ... do not have breast cancer). This correlation is often ...

Breast

https://docs.google.com/document/d/1sWQwqcSH23B30CKCVOaQ2kb4D4qES6YfPqmgJYR5rnY/edit
... breast cancer mortality or death from any cause. Neoadjuvant ... HRT Meta [Lancet '19]: Lean women see increases in breast cancer risk with menopausal HRT.

WO2015042246A1 - Combination of anti-lag-3 antibodies and anti ...

https://patents.google.com/patent/WO2015042246A1/da
... lobular carcinoma of the breast. Subjects with other prior malignancies ... breast cancer patients. Currently, there is a poor understanding of T cell ...

WO2018111104A1 - Use of human crispr sequences in diagnostics ...

https://patents.google.com/patent/WO2018111104A1/en
... Lobular carcinoma, Dysautonomia, Localized epiphyseal dysplasia, ... Breast Cancer, Male infertility, Malignant astrocytoma, Malignant brain tumors ...

US10780047B2 - Method of providing birth control - Google Patents

https://patents.google.com/patent/US10780047B2/en
The dose of replacement thyroid hormone or cortisol therapy may need to be in ... increase in tumor incidence was observed. In a 2-year intravaginal ...

EP2294089A2 - Anti-fn14 antibodies and uses thereof - Google ...

https://patents.google.com/patent/EP2294089A2/en
The two main types of breast cancer are ductal carcinoma and lobular carcinoma. ... Symptoms: Early breast cancer usually does not cause symptoms. As the cancer ...

US11559574B2 - Whole-cell cancer vaccines and methods for ...

https://patents.google.com/patent/US11559574B2/en
... breast cancer cell line or a breast cancer cell. In some instances, the ... does not have cancer or a population of subjects who do not have cancer.

WO2011139721A1 - Cancer biomarkers and methods of use thereof ...

https://patents.google.com/patent/WO2011139721A1/en
... breast cancer, and hormone dependent tumors of the breast. Nucleic acid ... cause other than breast cancer. Among the women who had subsequent invasive ...

EP2453908B1 - Bifunctional stapled polypeptides and uses thereof ...

https://patents.google.com/patent/EP2453908B1/en
... cancer Diseases 0.000 claims description 25; SLXKOJJOQWFEFD-UHFFFAOYSA-N 6 ... Breast cancer Diseases 0.000 claims description 3; 208000026310 Breast ...

US9610313B2 - Eye health composition and method using plant ...

https://patents.google.com/patent/US9610313B2/en
The carotenoids other than zeaxanthin and lutein that do enter the retina cause ... lobular tissue of the breast and by increasing hydration of the breast. The ...

US10925882B2 - System for providing birth control - Google Patents

https://patents.google.com/patent/US10925882B2/en
The dose of replacement thyroid hormone or cortisol therapy may need to be increased. ... increase in tumor incidence was observed. In a 2-year intravaginal ...

WO2017147600A1 - Whole-cell cancer vaccines and methods for ...

https://patents.google.com/patent/WO2017147600A1/en
... breast cancer cell line or a breast cancer cell. In some instances, the ... does not have cancer or a population of subjects who do not have cancer.

WO2015042246A1 - Combination of anti-lag-3 antibodies and anti ...

https://patents.google.com/patent/WO2015042246A1/en
... cancer, localized prostate cancer, carcinoma in situ of the cervix or carcinoma in situ of the bladder, or in situ ductal or lobular carcinoma of the breast.

WO2011008260A2 - Bifunctional stapled polypeptides and uses ...

https://patents.google.com/patent/WO2011008260A2/en
Inventive proteins preferably contain only natural amino acids, although non-natural amino acids (i.e., compounds that do not occur in nature but that can be ...

US10555929B2 - Methods for the treatment of nonalcoholic fatty ...

https://patents.google.com/patent/US10555929B2/en
Sep 15, 2016 ... ... Breast Cancer: In Vitro and In Vivo Studies," J. Clin. Endocrinol ... Cancer Causes Control, May 2009, 20:1523-8. Lin et al., "Lipid ...

CN102159257A - Drug delivery medical device - Google Patents

https://patents.google.com/patent/CN102159257A/en
... carcinoma, sarcoma, cutaneum carcinoma, digestive organs cancer, and breast cancer.5 FU 5 fluorouracil, however, causing serious adverse reaction such as ...

US20100239635A1 - Drug delivery medical device - Google Patents

https://patents.google.com/patent/US20100239635A1/en
... cancer, cancer of the digestive organs, and breast cancer. 5-Fluorouracil ... “Biocompatible” as used herein, refers to any material that does not cause ...